Vanuytsel LJ - Search Results

1

The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer.

Vanuytsel LJ, Vansteenkiste JF, Stroobants SG, De Leyn PR, De Wever W, Verbeken EK, Gatti GG, Huyskens DP, Kutcher GJ. Vanuytsel LJ, et al. Radiother Oncol. 2000 Jun;55(3):317-24. doi: 10.1016/s0167-8140(00)00138-9. Radiother Oncol. 2000. PMID: 10869746

2

Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?

Spaepen K, Stroobants S, Dupont P, Van Steenweghen S, Thomas J, Vandenberghe P, Vanuytsel L, Bormans G, Balzarini J, De Wolf-Peeters C, Mortelmans L, Verhoef G. Spaepen K, et al. J Clin Oncol. 2001 Jan 15;19(2):414-9. doi: 10.1200/JCO.2001.19.2.414. J Clin Oncol. 2001. PMID: 11208833

3

The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer.

Debois M, Oyen R, Maes F, Verswijvel G, Gatti G, Bosmans H, Feron M, Bellon E, Kutcher G, Van Poppel H, Vanuytsel L. Debois M, et al. Int J Radiat Oncol Biol Phys. 1999 Nov 1;45(4):857-65. doi: 10.1016/s0360-3016(99)00288-6. Int J Radiat Oncol Biol Phys. 1999. PMID: 10571190

4

A qualitative and a quantitative analysis of an auto-segmentation module for prostate cancer.

Huyskens DP, Maingon P, Vanuytsel L, Remouchamps V, Roques T, Dubray B, Haas B, Kunz P, Coradi T, Bühlman R, Reddick R, Esch AV, Salamon E. Huyskens DP, et al. Radiother Oncol. 2009 Mar;90(3):337-45. doi: 10.1016/j.radonc.2008.08.007. Epub 2008 Sep 21. Radiother Oncol. 2009. PMID: 18812252

5

The time course of development of late side effects after irradiation of the prostate with multiple fractions per day.

Lievens Y, Vanuytsel L, Rijnders A, Van Poppel H, van der Schueren E. Lievens Y, et al. Radiother Oncol. 1996 Aug;40(2):147-52. doi: 10.1016/0167-8140(96)01774-4. Radiother Oncol. 1996. PMID: 8884968

6

Breast conserving treatment of Paget's disease.

Bulens P, Vanuytsel L, Rijnders A, van der Schueren E. Bulens P, et al. Radiother Oncol. 1990 Apr;17(4):305-9. doi: 10.1016/0167-8140(90)90004-g. Radiother Oncol. 1990. PMID: 2160679

7

Effect of continuous infusion of bleomycin on the time for completion of repair of sublethal radiation damage in mouse lip mucosa during fractionated irradiation.

Vanuytsel L, Feng Y, Landuyt W, Thames HD Jr, van der Schueren E. Vanuytsel L, et al. Radiother Oncol. 1988 Aug;12(4):333-7. doi: 10.1016/0167-8140(88)90023-0. Radiother Oncol. 1988. PMID: 2460901

8

Practical implications of backscatter from outside the patient on the dose distribution during total body irradiation.

Van Dam J, Rijnders A, Vanuytsel L, Zhang HZ. Van Dam J, et al. Radiother Oncol. 1988 Nov;13(3):193-201. doi: 10.1016/0167-8140(88)90056-4. Radiother Oncol. 1988. PMID: 3065833

9

Radical prostatectomy can provide a cure for well-selected clinical stage T3 prostate cancer.

Van Poppel H, Goethuys H, Callewaert P, Vanuytsel L, Van de Voorde W, Baert L. Van Poppel H, et al. Eur Urol. 2000 Oct;38(4):372-9. doi: 10.1159/000020311. Eur Urol. 2000. PMID: 11025373

10

Radiotherapy for PSA recurrence after radical prostatectomy.

Vanuytsel L, Janssens G, Van Poppel H, Rijnders A, Baert L. Vanuytsel L, et al. Eur Urol. 2001 Apr;39(4):425-9. doi: 10.1159/000052480. Eur Urol. 2001. PMID: 11306881

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters